InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Pulsenmore Ltd.

PLSM Clue Score45
Israel Fiscal year ends December CIK 0002064764
$1.90 +4.40% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.90 −45.56% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 21 Jan 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2023Revenue6.2Net income−58.6EPS, diluted9.12Fiscal year 2024Revenue9.7 +56.1%Net income−36.7EPS, diluted5.76 −36.8%Fiscal year 2025Revenue40.0 +314.3%Net income−15.9EPS, diluted2.46 −57.3%
FY2023FY2024FY2025
Revenue 6.2 9.7 40.0
Growth +56.1% +314.3%
Net income −58.6 −36.7 −15.9
Growth
EPS, diluted 9.12 5.76 2.46
Growth −36.8% −57.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2023Gross margin35.6%Net margin−946.5%Free cash flow margin−866.0%Fiscal year 2024Gross margin37.0%Net margin−380.3%Free cash flow margin−434.4%Fiscal year 2025Gross margin84.2%Net margin−39.6%Free cash flow margin−82.5%
FY2023FY2024FY2025
Gross margin 35.6% 37.0% 84.2%
Net margin −946.5% −380.3% −39.6%
Free cash flow margin −866.0% −434.4% −82.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−49.7Capital expenditure−3.9Free cash flow−53.6Fiscal year 2024Operating cash flow−41.5Capital expenditure−0.5Free cash flow−42.0Fiscal year 2025Operating cash flow−32.9Capital expenditure−0.1Free cash flow−33.0
FY2023FY2024FY2025
Operating cash flow −49.7 −41.5 −32.9
Capital expenditure −3.9 −0.5 −0.1
Free cash flow −53.6 −42.0 −33.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2023Cash and securities23.9Shareholders’ equity132.2Fiscal year 2024Cash and securities41.2Shareholders’ equity96.9Fiscal year 2025Cash and securities21.6Shareholders’ equity83.1
FY2023FY2024FY2025
Cash and securities 23.9 41.2 21.6
Shareholders’ equity 132.2 96.9 83.1

In millions of ILS, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of ILS, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
6.2 9.7 40.0
Growth +56.1% +314.3%
4.0 6.1 6.3
2.2 3.6 33.7
Growth +62.5% +841.6%
31.4 20.1 17.4
17.0 15.3 16.7
−58.4 −36.8 −15.9
0.1 −0.1 0.0
−58.6 −36.7 −15.9
Growth
Per share
9.12 5.76 2.46
9.12 5.76 2.46
Growth −36.8% −57.3%
6.4 6.4 6.4
6.4 6.4 6.4
Growth +0.0% +0.6%

Shown in ILS as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 3 of 3 years on file.